TDC
BDSX icon

Thompson Davis & Co’s Biodesix BDSX Stock Holding History

Thompson Davis & Co’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$170K Buy
+11,750
New +$146K 0.11% 120

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Thompson Davis & Co's BDSX Position: Q1 2026 in Review

Thompson Davis & Co opened a new position in Biodesix (BDSX) in Q1 2026: 11,750 shares worth $170K. The stake represents 0.11% of the portfolio and ranks #120 among its holdings.

40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Thompson Davis & Co held 11,750 shares of Biodesix worth $170K as of Q1 2026.
  • Biodesix was a new Thompson Davis & Co position in Q1 2026.
  • Biodesix made up 0.11% of Thompson Davis & Co's portfolio in Q1 2026, its #120 holding.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Thompson Davis & Co's 13F filing for Q1 2026, filed 16 Apr 2026.